この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2011/3/151 分で読めます
Investigational New Drug Applications and Abbreviated New Drug Applications; Technical Amendment
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending its investigational new drug application (IND) regulations and abbreviated new drug application regulations to correct inaccurate cross-references to the IND regulations and the Federal Food, Drug, and Cosmetic Act (the FD&C Act). This action is being taken to ensure accuracy and clarity in the Agency's regulations.
情報源の原言語: Federal Register — Health and Human Services原文の発表を開く →